Dirk Böttcher
Finanzdirektor/CFO bei IBL International GmbH
Ursprung des Netzwerks ersten Grades von Dirk Böttcher
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
IBL International GmbH
 IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dirk Böttcher
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Abbott GmbH (Germany)
 Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| Kinderopvang Humanitas | Other Consumer Services | Director/Board Member | |
| STRATEC SE | Medical Specialties | Chairman | |
Tecan Deutschland GmbH
 Tecan Deutschland GmbH Medical SpecialtiesHealth Technology Part of Tecan Group AG, Tecan Deutschland GmbH develops, manufactures and distributes automated laboratory instruments and solutions. The company is based in Crailsheim, Germany. The CEOs of the German company are Rudolf Eugster, Richard Edward Patterson. | Medical Specialties | Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Isola Composites GmbH | Director of Finance/CFO | ||
| Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
| TECAN GROUP AG | Medical Specialties | Director of Finance/CFO | |
Tauw Group BV
 Tauw Group BV Miscellaneous Commercial ServicesCommercial Services Tauw Group BV engages in the environmental consultancy for the industrial sector. It focuses on the fields of environmental management and due diligence, soil management and remediation, spatial planning and site development, civil engineering and infrastructure, and water management and rural development. The company was founded on October 1, 1928 and is headquartered in Deventer, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| EPIGENOMICS AG | Medical Specialties | President | |
| Wageningen University | College/University | Undergraduate Degree | |
| Middenduin Life Sciences BV | Founder | ||
| University of Leiden | College/University | Doctorate Degree | |
ISA Pharmaceuticals BV
 ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Operating Officer | |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Biotechnology | President | |
| Technical University of Denmark | College/University | Undergraduate Degree | |
| GLYCOREX TRANSPLANTATION AB | Medical Specialties | Chief Executive Officer | |
| Martin-Luther-Universität Halle-Wittenberg | College/University | Undergraduate Degree |
Statistik
International
| Niederlande | 11 |
| Deutschland | 7 |
| Schweiz | 4 |
| Vereinigte Staaten | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 11 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Industrial Services | 2 |
Operativ
| Corporate Officer/Principal | 7 |
| Director/Board Member | 5 |
| Chief Executive Officer | 5 |
| Undergraduate Degree | 4 |
| President | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Dirk Böttcher
- Unternehmensverbindungen
